bankruptcy

Insys bankruptcy plan gets court OK
Insys bankruptcy plan gets court OK
Beckers Hospital Review
INSYS Therapeutics
bankruptcy
opioids
Flag link:
Bioresorbable scaffolds flounder as Reva heads to bankruptcy
Bioresorbable scaffolds flounder as Reva heads to bankruptcy
EP Vantage
devices
bioresorbable vascular scaffold
Abbott Labs
Amaranth
Reva Medical
bankruptcy
Flag link:
Antibiotics maker Melinta files for Chapter 11 bankruptcy
Antibiotics maker Melinta files for Chapter 11 bankruptcy
Reuters
Melinta Therapeutics
Chapter 11
bankruptcy
antibiotics
Flag link:
Audit: Sackler family took $10B from Purdue Pharma amid opioid suits
Audit: Sackler family took $10B from Purdue Pharma amid opioid suits
UPI
Purdue Pharma
Sackler family
oxycontin
bankruptcy
opioids
opioid crisis
Flag link:
Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs
Bankrupt Insys offers to turn out its almost empty pockets for plaintiffs
Fierce Pharma
Insys
bankruptcy
SEC
DOJ
Flag link:
Purdue to Pay States’ Legal Fees to Expedite Release of Emergency Funds
Purdue to Pay States’ Legal Fees to Expedite Release of Emergency Funds
Fierce Pharma
Purdue Pharma
bankruptcy
opioids
opioid crisis
Flag link:
The 11 biopharma companies that declared bankruptcy this year
The 11 biopharma companies that declared bankruptcy this year
Biopharma Dive
bankruptcy
Purdue Pharma
Achaogen
Pernix Therapeutics
Flag link:
31 biopharmas at high risk of bankruptcy in 2020
31 biopharmas at high risk of bankruptcy in 2020
Biopharma Dive
bankruptcy
Teva Pharmaceutical
Bausch Health
Novavax
Flag link:
Bankrupt biopharmas are rare. 2019 has some worried that's changing.
Bankrupt biopharmas are rare. 2019 has some worried that's changing.
Biopharma Dive
bankruptcy
Flag link:
Troubled poop-testing startup uBiome announces plans for liquidation
Troubled poop-testing startup uBiome announces plans for liquidation
Endpoints
uBiome
microbiome
bankruptcy
Flag link:
Amryt buys Aegerion via bankruptcy, adding sales to support R&D
Amryt buys Aegerion via bankruptcy, adding sales to support R&D
Fierce Biotech
Amryt Pharma
Aegerion
M&A
R&D
bankruptcy
AP101
Flag link:
Facing $4B in claims, Insys doubts ability to pay out via Chapter 11
Facing $4B in claims, Insys doubts ability to pay out via Chapter 11
Biopharma Dive
INSYS Therapeutics
bankruptcy
Flag link:
Embattled Purdue Pharma asks judge to authorize $34M in employee bonuses
Embattled Purdue Pharma asks judge to authorize $34M in employee bonuses
The Hill
Purdue Pharma
bankruptcy
bonuses
Flag link:
Sienna Biopharmaceuticals Files for Bankruptcy, Delaying Phase III Psoriasis Trial
Sienna Biopharmaceuticals Files for Bankruptcy, Delaying Phase III Psoriasis Trial
BioSpace
Sienna Biopharmaceuticals
bankruptcy
psoriasis
SNA-120
Flag link:
Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy
Purdue Pharma, maker of OxyContin and other drugs, files for bankruptcy
Stat
Purdue Pharma
oxycontin
bankruptcy
opioids
opioid crisis
Flag link:
Purdue talks may have stalled with state AGs, but cities and counties are still at it: AP
Purdue talks may have stalled with state AGs, but cities and counties are still at it: AP
Fierce Pharma
Purdue Pharma
opioids
opioid crisis
bankruptcy
Flag link:
Purdue preps bankruptcy as opioid settlement bid stumbles; report
Purdue preps bankruptcy as opioid settlement bid stumbles; report
Pharmaforum
Purdue Pharma
opioids
opioid crisis
bankruptcy
Flag link:
Mallinckrodt preps a possible bankruptcy amid a maelstrom of opioid claims — report
Mallinckrodt preps a possible bankruptcy amid a maelstrom of opioid claims — report
Endpoints
Mallinckrodt
opioids
opioid crisis
bankruptcy
Flag link:
Bankrupt uBiome Says Founders May Have Misled Investors
Bankrupt uBiome Says Founders May Have Misled Investors
Xconomy
uBiome
microbiome
bankruptcy
Flag link:
States Pause Lawsuits Against Insys During Bankruptcy Proceedings
States Pause Lawsuits Against Insys During Bankruptcy Proceedings
BioSpace
INSYS Therapeutics
bankruptcy
Flag link:

Pages